ND-095
N/A
Report date: 2026/04/17 20:02:02
First In Class
Base Information
Drug NameND-095
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNumab Therapeutics Ag
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A